跳至主要内容
临床试验/JPRN-UMIN000004029
JPRN-UMIN000004029招募中2 期

Multicenter randomized phase II trial of S-1/ L-OHP (SOX) as an adjuvant treatment after resection of liver metastasis from colorectal carcinoma - Randomized phase II trial of S-1/ L-OHP (SOX) as an adjuvant treatment after resection of liver metastasis from colorectal carcinoma

Yokohama City University Graduate School of Medicine Gastroenterological surgery0 个研究点目标入组 80 人开始时间: 2010年9月1日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • The patients with other malignant disease, post-operative severe complications, and surgical margin positivity.

研究者

发起方
Yokohama City University Graduate School of Medicine Gastroenterological surgery

相似试验

已完成
2 期
Multicenter phase II study of oral S-1 monotherapy in advanced colorectal cancer who have failed prior oxaliplatin and irinotecan-based therapiesColorectal cancer
JPRN-UMIN000006487Chube Clinical Oncology Group (CCOG)34
进行中(未招募)
1 期
A multicenter Phase I/II trial investigating the safety and efficacy (CR rate and OS) of low dose AraC with Clofarabine in patients =60 years with AML not eligible for conventionalChemotherapyMedDRA - 10000886, akute myeloische Leukämie, acute myeloid leukemiaC92.0Acute myeloblastic leukaemia [AML]
DRKS00000580niversität Leipzig13
进行中(未招募)
不适用
A multicenter Phase I/II trial investigating the safety and efficacy (CR rate and OS) of low dose AraC with Clofarabine in patients =60 years with AML not eligible for conventionalChemotherapy - ClofarabineAcute myeloid leukaemiaMedDRA version: 12.1Level: PTClassification code 10000880Term: Acute myeloid leukaemiaMedDRA version: 12.1Level: LLTClassification code 10000880Term: Acute myeloid leukaemia
EUCTR2009-017347-33-DEniversity of Leipzig60
暂停
2 期
WT1 peptide pulse dendritic cells vaccine therapy for pancreatic cancer following resectioPancreatic cancer
JPRN-jRCTc031190107Yanagisawa Ryu144
已完成
2 期
A Multicenter phase II study of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanved non-squamous non-small cell lung cancer
JPRN-UMIN000007386Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine28